Retatrutide
DISCLAIMER: This product is strictly for laboratory and in vitro research purposes only. It is not approved for human consumption, veterinary use, diagnostic, or therapeutic applications.
This lyophilized compound is a synthetic triple-agonist peptide designed to target the glucagon-like peptide-1 , glucose-dependent insulinotropic polypeptide , and glucagon receptors. It is formulated specifically for the investigation of complex metabolic and neuroendocrine signaling pathways in controlled laboratory environments. Current in vitro research utilizing this compound focuses on multi-receptor binding affinity, the modulation of cellular lipid metabolism (lipolysis) in isolated adipocyte cell cultures, and the evaluation of mitochondrial bioenergetics. This material is supplied exclusively as a laboratory reagent for advanced structural, functional, and biochemical studies.